PipelineReview.com6h
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
PLYMOUTH MEETING, PA, USA I March 13, 2025 I INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help ...
8 New Books We Recommend This Week
Suggested reading from critics and editors at The New York Times.
Scrub typhus hidden cause of hospitalisation, 10% of Tamil Nadu's rural population affected annually
Among those who were infected, 8 per cent to 15 per cent developed fever which often required hospital care, researchers said ...
PipelineReview.com20h
SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
BARCELONA, Spain I March 13, 2025 I SpliceBio, a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations ...
News Agency of the Slovak Republic21h
Kotlar Asks PG to Look into Results of Analysis of mRNA Vaccines against COVID
I'm asking Prosecutor-General Maros Zilinka to take immediate action regarding the results of an analysis of batches of vaccines used against COVID-19 among the Slovak population, Government Proxy for ...
The Atari Asteroids Watch Is So Beautiful, I Don’t Care How Poorly It Tells Time
Nubeo’s limited edition Atari Asteroids watch respects the manic nature of high-stakes arcade gaming.
Le Lézard9h
ENCell Signs MOU with Cell Resources Corporation to Pave Way for Market Entry to Japan
ENCell Co., Ltd., a South Korean biotech specializing in advanced biopharmaceutical contract development and manufacturing organizations (CDMO) and novel drug development, has signed an MOU for ...